CLINICAL_TRIALS
trial_result
· 2022-02-11
Clinical Trial Update: Evaluating Crizotinib in the Neoadjuvant Setting in Patients With Non-small Cell Lung Cancer [Phase 2]
Summary
Phase 2 trial evaluating crizotinib as neoadjuvant therapy in patients with non-small cell lung cancer has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Colorado, Denver | Conditions: Lung Cancer, Nonsmall Cell | Phase 2 | Status: COMPLETED | Results posted: 2022-02-11